Etomidate Injection shortage
Etomidate Injection is currently listed in shortage by the FDA. The FDA lists 18 affected products. The reported reason: Demand increase for the drug; Other. This page was last refreshed from FDA data on Sep 22, 2026.
Etomidate injection is in shortage, with the larger vial sizes (20 mg/10 mL and 40 mg/20 mL) currently having no available source. The 2 mg/mL strength is still listed as available from several manufacturers, including Fresenius Kabi, which has not reported a shortage.
Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers (see options) and your prescriber about a long-term plan.
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Etomidate Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Sep 17, 2026Currently in shortage18 of 18 products affected.
-
Sep 9, 2026FDA refreshed this shortage record1 product updated.
-
Sep 3, 2026FDA refreshed this shortage record5 products updated.
-
Aug 24, 2026FDA refreshed this shortage record1 product updated.
-
Aug 13, 2026FDA refreshed this shortage record1 product updated.
-
Jul 22, 2026FDA refreshed this shortage record2 products updated.
-
Jun 16, 2026FDA refreshed this shortage record4 products updated.
-
Oct 5, 2022First reported to the FDA18 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Caplin Steriles, Ltd. 📞 908-803-2586 4 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Etomidate, Injection, 2 mg/mL (NDC 72485-509-10) | — | Available | Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586 | — |
| Current | Etomidate, Injection, 2mg/mL (NDC 65219-447-20) | — | Available | Check wholesalers for inventory; Marketed by Fresenius Kabi | — |
| Current | Etomidate, Injection, 2mg/1 mL (NDC 65219-445-10) | — | Available | Check wholesalers for inventory; Marketed by Fresenius Kabi | — |
| Current | Etomidate, Injection, 2 mg/mL (NDC 72485-508-10) | — | Available | Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586 | — |
Manufacturer: Eugia US LLC 📞 888-238-7880 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20) | — | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
| Current | Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10) | — | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
Manufacturer: Gland Pharma Limited 📞 833-291-9645 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10) | — | Available | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. | — |
| Current | Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10) | — | Available | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. | — |
Manufacturer: Hikma Pharmaceuticals USA, Inc. 📞 800-631-2174 6 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10) | — | Available | Distributed by Civica | — |
| Current | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10) | — | Available | Additional product will be made available as it is released. | — |
| Current | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10) | — | Available | Novaplus label | — |
| Current | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10) | — | Available | Novaplus label | — |
| Current | Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10) | — | Available | Distributed by Civica | — |
| Current | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10) | — | Available | Additional product will be made available as it is released. | — |
Manufacturer: Hospira, Inc., a Pfizer Company 📞 844-646-4398 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01) | — | Available | — | — |
| Current | Amidate, Injection, 2 mg/mL (NDC 0409-6695-02) | — | Unavailable | Next Delivery: November 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay | Other |
Manufacturer: Mylan Institutional, a Viatris Company 📞 800-796-9526 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20) | — | Available | — | — |
| Current | Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10) | — | Available | — | — |
These rows are manufacturer reports to the FDA for Etomidate Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Etomidate Injection? options further down this page.
Why is Etomidate Injection in shortage?
Etomidate injection (2 mg/mL) is on the FDA shortage list mainly because more people need it than the current supply can keep up with, and there are also some manufacturing hold-ups at certain facilities. Specifically, two of Eugia US LLC's products — the 20 mg/10 mL and 40 mg/20 mL vials — are both on backorder with no confirmed recovery date yet. On top of that, one of Hospira's (a Pfizer company) Amidate 2 mg/mL products is currently unavailable due to a manufacturing delay, with the next delivery not expected until November 2026 and a recovery estimated around December 2026.
It's worth knowing that Hospira's other Amidate 2 mg/1 mL product is still available, and several other manufacturers — including Hikma, Mylan, Caplin Steriles, and Gland Pharma — are reporting their 2 mg/mL vials as currently available, though some note that inventory may be limited and you'd need to check with wholesalers. This shortage report only reflects what these specific manufacturers have shared with the FDA.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Etomidate Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Etomidate Injection?
Etomidate injection is currently on the FDA drug-shortage list. Because this medicine is given in clinical settings such as hospitals and procedure areas, most of what follows is handled by your care team, but I want you to understand where supply stands.
The affected sizes are the 20 mg/10 mL and 40 mg/20 mL vials, which currently have no available source and are on backorder with a recovery time still to be determined. The smaller 2 mg/mL (also listed as 2 mg/1 mL) concentration still has supply reported from several makers, so the strength many patients receive is generally obtainable.
This shortage has lasted more than a year, and the reported reasons are increased demand and "other" factors. Importantly, 5 of 6 manufacturers still report available supply, so this is a limited-source issue rather than a full outage.
Here is what you can do:
- Do not skip or change any dose on your own — this medicine is dosed and given by your care team.
- If your setting uses the 2 mg/mL size, your pharmacy can order it and check wholesalers and other manufacturers.
- If the 10 mL or 20 mL vial you need cannot be found, your pharmacist or prescriber can discuss options, such as using an available concentration.
- Manufacturer contact numbers are listed on this page for reference; pharmacies usually make these calls.
This is national, manufacturer-reported data and may not match local stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Etomidate Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Etomidate Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Etomidate | ETOMIDATE 2 mg/mL | Injection, Solution · Intravenous | Fresenius Kabi USA, LLC | 65219-0445-22 |
Therapeutic equivalents & pricing 25 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Etomidate 2 mg/mL | Hikma | 10 vials | — | AP | FDA listed |
| Etomidate 2 mg/mL | Hikma | 10 vials | — | AP | FDA listed |
| Amidate 2 mg/mL | Hospira, | 10 vials | — | AP | FDA listed |
| Etomidate 40 mg/20mL | HF | 20 ml | — | AP | FDA listed |
| Etomidate 40 mg/20mL | Eugia | 10 vials | — | AP | FDA listed |
| Etomidate 2 mg/mL | Caplin | 10 vials | — | AP | FDA listed |
| Etomidate 2 mg/mL | Fresenius | 10 vials | — | AP | FDA listed |
| Etomidate 2 mg/mL | Mylan | 10 vials | — | AP | FDA listed |
| Etomidate 2 mg/mL | Gland | 10 vials | — | AP | FDA listed |
| Etomidate 2 mg/mL | Fosun | 10 vials | — | AP | FDA listed |
| Etomidate 2 mg/mL | Armas | 10 vials | — | AP | FDA listed |
| Etomidate 2 mg/mL | Civica, | 10 vials | — | AP | FDA listed |
| Etomidate 2 mg/mL | Hikma | 10 vials | — | AP | FDA listed |
| Etomidate 2 mg/mL | Hikma | 10 vials | — | AP | FDA listed |
| Etomidate 2 mg/mL | Fresenius | 10 vials | — | AP | FDA listed |
| Etomidate 2 mg/mL | Civica, | 10 vials | — | AP | FDA listed |
| Etomidate 2 mg/mL | HF | 10 ml | — | AP | FDA listed |
| Etomidate 2 mg/mL | Armas | 10 vials | — | AP | FDA listed |
| Amidate 2 mg/mL | Henry | 1 vial | — | AP | FDA listed |
| Etomidate 2 mg/mL | Mylan | 10 vials | — | AP | FDA listed |
| Etomidate 2 mg/mL | Caplin | 10 vials | — | AP | FDA listed |
| ETOMIDATE injection, solution 20 mg/10mL | HF | 10 ml | — | AP | FDA listed |
| Etomidate 20 mg/10mL | Eugia | 10 vials | — | AP | FDA listed |
| Etomidate 2 mg/mL | Gland | 10 vials | — | AP | FDA listed |
| Etomidate 2 mg/mL | Fosun | 10 vials | — | AP | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Etomidate Injection — that fall in the same broad treatment class (general anesthetics,injectable) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other anesthesia shortages
Etomidate Injection shortage FAQs
Is Etomidate Injection in shortage?
Why is Etomidate Injection in shortage?
Which products are affected?
When will Etomidate Injection be available again?
Can I still get Etomidate somewhere?
What should I do if I take Etomidate Injection?
Still have a question about the Etomidate Injection shortage?
Ask a pharmacist about this shortage →View Etomidate Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.